Article Details

Immix Biopharma Loses US$9.2m Market Value But Insiders See Windfall Of US$19k

Retrieved on: 2025-08-08 13:47:11

Tags for this article:

Click the tags to see associated articles and topics

Immix Biopharma Loses US$9.2m Market Value But Insiders See Windfall Of US$19k. View article details on hiswai:

Excerpt

Insiders who bought Immix Biopharma, Inc. ( NASDAQ:IMMX ) in the last 12 months may probably not pay attention to the...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo